Compare GME & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GME | MEDP |
|---|---|---|
| Founded | 1996 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electronics Distribution | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.7B | 11.9B |
| IPO Year | 2005 | 2016 |
| Metric | GME | MEDP |
|---|---|---|
| Price | $22.58 | $456.00 |
| Analyst Decision | Sell | Hold |
| Analyst Count | 1 | 12 |
| Target Price | $13.50 | ★ $473.17 |
| AVG Volume (30 Days) | ★ 6.1M | 292.9K |
| Earning Date | 06-09-2026 | 04-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 133.33 | 20.98 |
| EPS | 0.77 | ★ 4.28 |
| Revenue | ★ $3,629,900,000.00 | N/A |
| Revenue This Year | $18.98 | $13.19 |
| Revenue Next Year | N/A | $7.75 |
| P/E Ratio | ★ $28.73 | $105.33 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $19.94 | $294.07 |
| 52 Week High | $30.60 | $628.92 |
| Indicator | GME | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 49.25 | 59.19 |
| Support Level | $22.35 | $452.55 |
| Resistance Level | $22.95 | $483.30 |
| Average True Range (ATR) | 0.59 | 14.39 |
| MACD | 0.05 | 5.16 |
| Stochastic Oscillator | 56.35 | 91.47 |
GameStop Corp offers games, collectibles, and entertainment products through its stores and ecommerce platforms. Its products include Hardware and accessories offering new and pre-owned gaming platforms from the console manufacturers, Software offering new and pre-owned gaming software for current and certain prior generation consoles and sell a wide range of in-game digital currency, digital downloadable content and full-game downloads, and Collectibles consist of apparel, toys, trading cards, gadgets and other retail products for pop culture and technology enthusiasts and collectibles related services, such as submission services for the authentication and grading of trading cards. The company operates its business in three geographic segments: the United States, Australia, and Europe.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.